Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Needlestick Prevention Claims Require Support Of Clinical Data, Panel Says

This article was originally published in The Gray Sheet

Executive Summary

Clinical data demonstrating efficacy of a sharps injury prevention device should be submitted to FDA in support of any claim, suggestion, or hint that the device reduces the incidence of sharps injury, FDA's General Hospital and Personal Use Devises Advisory Panel concluded.

You may also be interested in...

OSHA Standards Could Prompt Federal, State Safety Needle Bill Passage

Release of OSHA's bloodborne pathogen standards will not preclude Congress from addressing legislation in the next session that would require hospitals to use safety needle devices, Capitol Hill staffers say.

Novavax May Seek COVID-19 Vaccine Emergency Authorization In US Based On UK Data

With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts